These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


505 related items for PubMed ID: 24720436

  • 1. Combining bioinformatics and MS-based proteomics: clinical implications.
    Acosta-Martin AE, Lane L.
    Expert Rev Proteomics; 2014 Jun; 11(3):269-84. PubMed ID: 24720436
    [Abstract] [Full Text] [Related]

  • 2. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 15; 847(1):3-11. PubMed ID: 17023222
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bioinformatics challenges in mass spectrometry-driven proteomics.
    Martens L.
    Methods Mol Biol; 2011 Feb 15; 753():359-71. PubMed ID: 21604135
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins.
    Boja ES, Rodriguez H.
    Proteomics; 2012 Apr 15; 12(8):1093-110. PubMed ID: 22577011
    [Abstract] [Full Text] [Related]

  • 8. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
    Thomas A, Lenglet S, Chaurand P, Deglon J, Mangin P, Mach F, Steffens S, Wolfender JL, Staub C.
    Thromb Haemost; 2011 Jul 15; 106(1):20-33. PubMed ID: 21614412
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H, Schanstra JP.
    Proteomics Clin Appl; 2011 Feb 15; 5(1-2):9-23. PubMed ID: 21280234
    [Abstract] [Full Text] [Related]

  • 11. Expanding the organismal scope of proteomics: cross-species protein identification by mass spectrometry and its implications.
    Liska AJ, Shevchenko A.
    Proteomics; 2003 Jan 15; 3(1):19-28. PubMed ID: 12548630
    [Abstract] [Full Text] [Related]

  • 12. Bioinformatics tools to identify and quantify proteins using mass spectrometry data.
    Ryu SY.
    Adv Protein Chem Struct Biol; 2014 Jan 15; 94():1-17. PubMed ID: 24629183
    [Abstract] [Full Text] [Related]

  • 13. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.
    Elschenbroich S, Ignatchenko V, Clarke B, Kalloger SE, Boutros PC, Gramolini AO, Shaw P, Jurisica I, Kislinger T.
    J Proteome Res; 2011 May 06; 10(5):2286-99. PubMed ID: 21491939
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protein mass spectra data analysis for clinical biomarker discovery: a global review.
    Roy P, Truntzer C, Maucort-Boulch D, Jouve T, Molinari N.
    Brief Bioinform; 2011 Mar 06; 12(2):176-86. PubMed ID: 20534688
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recent advances in clinical proteomics using mass spectrometry.
    Dowling P, Meleady P, Henry M, Clynes M.
    Bioanalysis; 2010 Sep 06; 2(9):1609-15. PubMed ID: 21083289
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.